These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18034520)

  • 1. Therapy for alpha1-antitrypsin deficiency: pharmacology and clinical recommendations.
    Minai OA; Stoller JK
    BioDrugs; 2000 Feb; 13(2):135-47. PubMed ID: 18034520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.
    Petrache I; Hajjar J; Campos M
    Biologics; 2009; 3():193-204. PubMed ID: 19707408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1 Antitrypsin Deficiency: Current Perspective from Genetics to Diagnosis and Therapeutic Approaches.
    Santangelo S; Scarlata S; Poeta ML; Bialas AJ; Paone G; Incalzi RA
    Curr Med Chem; 2017; 24(1):65-90. PubMed ID: 27855621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
    Janciauskiene S; Welte T
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
    Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
    Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-antitrypsin-deficiency-related emphysema.
    Barker AF
    J Am Board Fam Pract; 1992; 5(5):489-93. PubMed ID: 1414450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
    Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
    Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons from the Past: Some Histories of Alpha-1 Antitrypsin Deficiency Before Its Discovery.
    Perciaccante A; Charlier P; Negri C; Coralli A; Appenzeller O; Bianucci R
    COPD; 2018 Feb; 15(1):1-3. PubMed ID: 29469675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha1-antitrypsin deficiency.
    Stoller JK; Aboussouan LS
    Lancet; 2005 Jun 25-Jul 1; 365(9478):2225-36. PubMed ID: 15978931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.
    Marciniuk DD; Hernandez P; Balter M; Bourbeau J; Chapman KR; Ford GT; Lauzon JL; Maltais F; O'Donnell DE; Goodridge D; Strange C; Cave AJ; Curren K; Muthuri S;
    Can Respir J; 2012; 19(2):109-16. PubMed ID: 22536580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
    Geraghty P; Rogan MP; Greene CM; Brantly ML; O'Neill SJ; Taggart CC; McElvaney NG
    Thorax; 2008 Jul; 63(7):621-6. PubMed ID: 18250185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-1 antitrypsin (AAT) deficiency - what are the treatment options?
    Modrykamien A; Stoller JK
    Expert Opin Pharmacother; 2009 Nov; 10(16):2653-61. PubMed ID: 19827990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of α1-antitrypsin deficiency.
    Stoller JK; Aboussouan LS
    Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between pulmonary function impairment and levels of alpha1-antitrypsin in serum and colon of ulcerative colitis patients: a clinical research].
    Wang JY; Wang XY; Sun HY; Liu DM; Zhang W; Jin CX; Li L; Zhu LQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):20-6. PubMed ID: 24520781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.